自动化微生物市场规模、份额和成长分析（按样品类型、产品类型、自动化程度、应用、最终用户和地区划分）－2026-2033年产业预测

全球自动化微生物市场规模预计在 2024 年达到 90 亿美元，从 2025 年的 99.9 亿美元成长到 2033 年的 230.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 11.0%。

由于感染疾病日益普遍，全球自动化微生物市场正经历显着成长。医疗相关感染疾病、抗药性病原体和食源性疾病的增加，推动了对快速、准确的微生物鑑定和药敏试验的需求激增。自动化微生物系统利用质谱、基于PCR的检测和人工智慧驱动的鑑定等先进技术，提高了诊断准确性并缩短了检测週期。自动化技术在实验室环境中的应用，提高了营运效率，提升了生产力并加快了处理速度。基于云端的资料管理实现了即时监控和协作，而对品管和法规遵循的重视，则推动了软体和设备的进步。供应商和医疗机构之间的合作，促进了诊断检查室的创新客製化解决方案的开发，进一步支持了市场成长。

全球自动化微生物市场驱动因素

全球自动化微生物市场的主要驱动力是医疗机构对快速、准确诊断检测日益增长的需求。感染疾病的日益流行，以及对病人安全和感染控制的日益重视，正促使医疗机构采用自动化微生物解决方案。这些技术不仅简化了检查室流程，还减少了人为错误，并能更快提供检测结果。此外，自动化和人工智慧技术的进步正在提高微生物分析的可靠性和准确性，进一步推动了其在全球医院、诊断检查室和研究实验室的应用。

全球自动化微生物市场限制因素

全球自动化微生物市场的主要限制因素之一是先进自动化系统所需的高额初始投资。小规模检查室和医疗机构往往面临预算限制，这限制了它们实施先进微生物自动化技术的能力。此外，专业培训和维护的需求进一步增加了成本，令潜在采用者望而却步。这种经济障碍可能会阻碍自动化解决方案在微生物领域的广泛应用和发展，尤其是在资源有限的发展中地区。因此，市场普及速度可能会放缓，进而影响该领域的整体成长和创新。

全球自动化微生物市场趋势

全球自动化微生物市场正经历重大变革，人工智慧和智慧自动化正在融合，彻底革新传统的微生物检测流程。借助先进的机器学习技术，这一趋势显着提升了预测性诊断、影像分析和菌落识别能力，大幅提高了准确性并减少了人为误差。复杂智能的实验室生态系的普及进一步促进了诊断决策中的协作与合作。云端分析和远端监控解决方案的日益普及有望变革检查室运营，提高效率并简化工作流程。自动化与数据智慧的融合，使自动化微生物检测成为未来医疗保健和诊断的关键组成部分。

目录

介绍

• 调查目标
• 市场定义和范围

调查方法

• 调查过程
• 二手资料和一手资料方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争格局概述

市场动态与展望

• 总体经济指标
• 驱动因素和机会
• 限制与挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 技术评估

全球自动化微生物市场规模（按样品类型和复合年增长率划分）（2026-2033 年）

• 血
• 尿
• 组织
• 食物
• 水

全球自动化微生物市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 自动培养箱
• 自动菌落计数器
• 自动微生物分析仪
• 自动化培养基製备系统

全球自动化微生物市场规模（按自动化程度和复合年增长率划分）（2026-2033 年）

• 半自动
• 全自动

全球自动化微生物市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 临床领域
• 食品/饮料
• 製药
• 环境领域

全球自动化微生物市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 医院和诊所
• 参考检验机构
• 研究所
• 食品和饮料公司
• 製药公司

全球自动化微生物市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• bioMerieux SA
• Becton, Dickinson and Company（BD）
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• COPAN Group
• Bruker Corporation
• Roche Diagnostics
• Abbott Laboratories
• Rapid Micro Biosystems, Inc.
• Merck KGaA
• Charles River Laboratories International, Inc.
• Siemens Healthineers AG
• Agilent Technologies, Inc.
• QIAGEN NV
• Hologic, Inc.
• Bio-Rad Laboratories, Inc.
• Synbiosis
• Clever Culture Systems（CCS）
• Microbiology International
• Zhuhai Meihua Medical Technology Ltd.

结论与建议

Global Automated Microbiology Market size was valued at USD 9.0 billion in 2024 and is poised to grow from USD 9.99 billion in 2025 to USD 23.02 billion by 2033, growing at a CAGR of 11.0% during the forecast period (2026-2033).

The global automated microbiology market is experiencing significant growth driven by the rising prevalence of infectious diseases. The demand for swift and accurate microbiological identification and susceptibility testing has surged due to healthcare-associated infections, antibiotic-resistant pathogens, and foodborne illnesses. Automated microbiology systems enhance diagnostic accuracy and reduce turnaround times using advanced technologies such as mass spectrometry, PCR-based detection, and AI-driven identification. The integration of automation in laboratory settings is revolutionizing operations, ensuring improved productivity and expedited processing. Cloud-based data management facilitates real-time monitoring and collaboration, while a focus on quality control and regulatory compliance propels advancements in software and instruments. Collaborations between suppliers and healthcare providers are fostering the development of innovative, tailored solutions for diagnostic laboratories, further propelling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Automated Microbiology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Automated Microbiology Market Segments Analysis

Global Automated Microbiology Market is segmented by Sample Type, Product Type, Automation Level, Application, End User and region. Based on Sample Type, the market is segmented into Blood, Urine, Tissue, Food and Water. Based on Product Type, the market is segmented into Automated Incubators, Automated Colony Counters, Automated Microbiology Analyzers and Automated Media Preparation Systems. Based on Automation Level, the market is segmented into Semi-Automated and Fully Automated. Based on Application, the market is segmented into Clinical, Food and Beverage, Pharmaceutical and Environmental. Based on End User, the market is segmented into Hospitals and Clinics, Reference Laboratories, Research Institutions, Food and Beverage Companies and Pharmaceutical Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Automated Microbiology Market

A key market driver for the Global Automated Microbiology Market is the increasing demand for rapid and accurate diagnostic testing in healthcare settings. The rising prevalence of infectious diseases, coupled with the growing focus on patient safety and infection control, propels healthcare facilities to adopt automated microbiological solutions. These technologies not only enhance the efficiency of laboratory processes but also reduce human error, leading to quicker turnaround times for test results. Moreover, advancements in automation and artificial intelligence improve the reliability and accuracy of microbiological analyses, further encouraging adoption across hospitals, diagnostics laboratories, and research institutions globally.

Restraints in the Global Automated Microbiology Market

One key market restraint for the global automated microbiology market is the high initial investment required for sophisticated automated systems. Smaller laboratories and healthcare facilities often face budget constraints, limiting their ability to acquire advanced microbiology automation technologies. Additionally, the need for specialized training and maintenance further exacerbates costs, leading to apprehension among potential adopters. This financial barrier can hinder the widespread implementation and growth of automated solutions in microbiology, particularly in developing regions where resources are more limited. As a result, the market may experience slow adoption rates, affecting overall growth and innovation in the sector.

Market Trends of the Global Automated Microbiology Market

The Global Automated Microbiology market is experiencing a significant shift towards the integration of AI and intelligent automation, revolutionizing traditional microbiological processes. Leveraging advanced machine learning techniques, this trend enhances predictive diagnostics, image analysis, and colony recognition, thereby dramatically improving accuracy and reducing human error. The adoption of sophisticated, intelligent lab ecosystems further fosters connectivity and collaboration in diagnostic decision-making. As cloud analytics and remote monitoring solutions gain traction, they promise to transform laboratory operations, driving efficiency and streamlining workflows. This convergence of automation and data intelligence positions automated microbiology as a critical component in the future of healthcare and diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Automated Microbiology Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Blood
• Urine
• Tissue
• Food
• Water

Global Automated Microbiology Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Automated Incubators
• Automated Colony Counters
• Automated Microbiology Analyzers
• Automated Media Preparation Systems

Global Automated Microbiology Market Size by Automation Level & CAGR (2026-2033)

• Market Overview
• Semi-Automated
• Fully Automated

Global Automated Microbiology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical
• Food and Beverage
• Pharmaceutical
• Environmental

Global Automated Microbiology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Reference Laboratories
• Research Institutions
• Food and Beverage Companies
• Pharmaceutical Companies

Global Automated Microbiology Market Size & CAGR (2026-2033)

• North America (Sample Type, Product Type, Automation Level, Application, End User)
  • US
  • Canada
• Europe (Sample Type, Product Type, Automation Level, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Sample Type, Product Type, Automation Level, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Sample Type, Product Type, Automation Level, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Sample Type, Product Type, Automation Level, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COPAN Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Micro Biosystems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbiosis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clever Culture Systems (CCS)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microbiology International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhuhai Meihua Medical Technology Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations